Abstract
Objective: Acute promyelocytic leukemia (APL) with variant RARA translocation, eg, t(11;17), is not sensitive to all-trans retinoic acid and requires distinct chemotherapy. However, there are some leukemic entities that may mimic aspects of the clinical and/or laboratory picture of APL and cause confusion because of karyotype nomenclature. Therefore, recognition of such entities may be of therapeutic and prognostic significance. Methods: We present 2 cases of acute myeloid leukemia (AML) with t(11;17) that were clinically concerning for APL based primarily on clinical presentation but were ultimately diagnosed as AML with monocytic differentiation. Results: Both leukemias harbored KMT2A translocations, one located near but not involving RARA and the other with SEPT9. Conclusion: In leukemias that clinically and/or immunophenotypically mimic APL, identification of specific gene translocations can lead to the correct diagnosis and may carry therapeutic/prognostic implications.
Author supplied keywords
Cite
CITATION STYLE
Balbuena-Merle, R. I., Tormey, C. A., Diadamo, A., Rinder, H. M., & Siddon, A. J. (2021). Monocytic Acute Myeloid Leukemias with KM2TA Translocations to Chromosome 17q that May Clinically Mimic Acute Promyelocytic Leukemia. Lab Medicine, 52(3), 290–296. https://doi.org/10.1093/labmed/lmaa078
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.